Effect of Melissa officinalis L. on human breast cancer cell line via apoptosis and autophagy
Öz
Purpose: The aim of this research is to see how Melissa officinalis L. affects the death pathways of MCF-7 breast cancer cells in vitro.
Materials and Methods: In order to determine the cytotoxic activity and IC50 value of the 70% methanolic extract prepared from the aerial parts of Melissa officinalis, on the MCF-7 breast cancer cell line; the extract was applied at different concentrations and times and MTT analysis was performed. Apoptotic effects of Melissa officinalis on breast cancer cells at the determined IC50 dose were revealed by TUNEL method, and autophagic effects were revealed using Beclin-1 and LC3 immunofluorescence staining method.
Results: When the effects of Melissa officinalis on MCF-7 breast cancer cells were evaluated, it was observed that the cell viability of the MCF-7 breast cancer cell line was decreased in a dose- and time-dependent manner. In addition, it was observed that it induced apoptosis and increased the immunoreactivity of autophagy markers Beclin-1 and LC3.
Conclusion: Findings from the study showed that Melissa officinalis has a cytotoxic effect on MCF-7 breast cancer cells through both apoptosis and autophagy cell death pathways. These data will lead to further in vitro studies necessary to elucidate the antitumor mechanism of action.
Anahtar Kelimeler
MCF-7 cell line, Melissa officinalis L., apoptosis, autophagy
Kaynakça
- REFERENCES 1- Akkuzu MZ, Küçüköner M, Irtegun S, Akdeniz N, Urakçı Z, Kaplan MA et al. Meme kanserinde Brca-1 ve Brca-2’ de sık görülen polimorfizm mutasyonların bölgemizde varlığı. Dicle Med J. 2019;46(4):623–631.
- 2- Kampa M, Nifli AP, Notas G, Castanas E. Polyphenols and cancer cell growth. Rev Physiol Biochem Pharmacol. 2007;159:79–113.
- 3- Sonnenblick A, Fumagalli D, Sotiriou C, Piccart M. Is the differentiation into molecular subtypes of breast cancer important for staging, local and systemic therapy, and follow up? Cancer Treat Rev. 2014;40:1089-1095.
- 4- Eliyatkin N, Yalcin E, Zengel B, Aktaş S, Vardar E. Molecular classification of breast carcinoma: from traditional, old-fashioned way to a new age, and a new way. J Breast Heal. 2015;11:59-66.
- 5- Comsa S, Cîmpean AM, Raica M. The story of MCF-7 breast cancer cell line: 40 Years of experience in research. Anticancer Res. 2015;35:3147–3154.
- 6- Sweeney EE, McDaniel RE, Maximov PY, Fan P, Craig Jordan V. Models and mechanisms of acquired antihormone resistance in breast cancer: Significant clinical progress despite limitations. Horm Mol Biol Clin Investig. 2012;9(2):143–163.
- 7- Baskal G, Köngül E, Karatoprak GS. Traditional Usage of Melissa officinalis. Journal of Health Sciences. 2017;26: 267-269.
- 8- Gurbuz P, Martinez A, Perez C, Martinez-Gonzalez L, Goger F, Ayran I. Potential anti-Alzheimer effects of selected Lamiaceae plants through polypharmacology on glycogen synthase kinase-3β, β-secretase, and casein kinase 1δ. Industrial Crops & Products. 2019; 138:111431.
- 9- Saraydin SU, Tuncer E, Tepe B, Karadayi S, Özer H, Şen M, et al. Antitumoral Effects of Melissa officinalis on Breast Cancer in vitro and in vivo. Asian Pacific journal of cancer prevention: APJCP. 2012;13:2765-70.
- 10- Weidner C, Rousseau M, Plauth A, Wowro SJ, Fischer C, Abdel-Aziz H, et al. Melissa officinalis extract induces apoptosis and inhibits proliferation in colon cancer cells through formation of reactive oxygen species. Phytomedicine. 2015;22:262-270.
